QSAM Biosciences, Inc.
QSAM · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $21,536 | $7,489 | $142 | $139 |
| - Cash | $1,386 | $225 | $1,500 | $8 |
| + Debt | $8 | $451 | $575 | $3,942 |
| Enterprise Value | $20,157 | $7,715 | -$782 | $4,074 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$372,938,000 |
| % Margin | – | – | – | – |
| EBITDA | $36,295,660 | -$5,371 | -$11,696 | -$5,330 |
| % Margin | – | – | – | – |
| Net Income | -$4,393 | -$6,075 | -$12,766 | -$5,353 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.24 | -3.45 | -16.13 | -19.57 |
| % Growth | 64.1% | 78.6% | 17.6% | – |
| Operating Cash Flow | -$2,848 | -$2,712 | -$1,769 | -$743 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,848 | -$2,712 | -$1,769 | -$743 |